These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3579056

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. Reliability of salivary theophylline concentration monitoring in children with bronchial asthma following the administration of different drug formulations.
    Boner AL, Valletta EA, Plebani M, Biancotto R, Bellanti JA.
    Allergol Immunopathol (Madr); 1985; 13(5):393-8. PubMed ID: 4083233
    [Abstract] [Full Text] [Related]

  • 43. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
    Goldstein MF, Chervinsky P.
    Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
    [Abstract] [Full Text] [Related]

  • 44. Metaproterenol sulfate for asthmatic children with therapeutic serum theophylline concentrations.
    Kelly HW, Menendez R, Murphy S, Tuttle W.
    Clin Pharm; 1982 Apr; 1(1):49-54. PubMed ID: 6764162
    [Abstract] [Full Text] [Related]

  • 45. [Clinical use of theophylline retard Oranienburg].
    Slapke J, Hummel S, Wilke A, Wenz W, Meister W, Förster R, Wiesner B, Rentsch E, Nussbücker B.
    Z Erkr Atmungsorgane; 1988 Apr; 170(1):49-53. PubMed ID: 3291417
    [Abstract] [Full Text] [Related]

  • 46. Pharmacokinetics of a new theophylline liquid in asthmatic children.
    Pedersen S.
    Eur J Respir Dis; 1983 Jan; 64(1):47-50. PubMed ID: 6825748
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. [Monitoring long-term therapy with theophylline preparations in children with asthma].
    Lindemann H, Bauer J, Schwandt HJ.
    Monatsschr Kinderheilkd; 1985 Feb; 133(2):106-10. PubMed ID: 3920513
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. [Therapeutic and toxic theophylline levels in asthma attacks--is there a need for additional theophylline?].
    Zeidman A, Gardyn J, Fradin Z, Fink G, Mittelman M.
    Harefuah; 1997 Jul; 133(1-2):3-5, 80. PubMed ID: 9332046
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Sustained release theophylline for the forgetful asthmatic.
    Weinstein AG.
    Ann Allergy; 1985 Oct; 55(4):563-7. PubMed ID: 4051262
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [Control of inhaled triggering factors decreases prolonged drug therapy requirements in patients with asthma].
    Hernández M, Salmen S, Berrueta L, Navas M, Sánchez B, Muñoz J, Delgado R, Romano E, Rangel A.
    Invest Clin; 2000 Mar; 41(1):3-18. PubMed ID: 10758695
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. [Anhydrous theophylline in micropellets with prolonged action in asthmatic children].
    Massey LF, Escobedo V.
    Rev Alerg Mex (1987); 1989 Mar; 36(6):245-51. PubMed ID: 2699068
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.